Federal
Secure Data and Privacy for Contact Tracing Act of 2020
Source: Congress.gov ·
2,580 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
116TH CONGRESS
2D SESSION
S. 5027
To authorize the Director of the Centers for Disease Control and Prevention
to award grants to eligible State, Tribal, and territorial public health
agencies to develop and administer a program for digital contact tracing
for COVID–19, and for other purposes.
IN THE SENATE OF THE UNITED STATES
DECEMBER 16, 2020
Mr. SCHATZ (for himself and Ms. BALDWIN) introduced the following bill;
which was read twice and referred to the Committee on Health, Edu-
cation, Labor, and Pensions
A BILL
To authorize the Director of the Centers for Disease Control
and Prevention to award grants to eligible State, Tribal,
and territorial public health agencies to develop and ad-
minister a program for digital contact tracing for
COVID–19, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Secure Data and Pri-
4
vacy for Contact Tracing Act of 2020’’.
5
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
2
•S 5027 IS
SEC. 2. GRANT PROGRAM FOR DIGITAL CONTACT TRACING
1
FOR COVID–19.
2
(a) IN GENERAL.—The Director of the Centers for
3
Disease Control and Prevention shall award grants to eli-
4
gible State, Tribal, and territorial public health agencies
5
to—
6
(1) establish a contact tracing program that im-
7
plements traditional contact tracing protocols with
8
the assistance of digital contact-tracing technology
9
to track and prevent the spread of COVID–19;
10
(2) incorporate digital contact-tracing tech-
11
nology into a contact tracing program that imple-
12
ments traditional contact tracing protocols to track
13
and prevent the spread of COVID–19; and
14
(3) expand or maintain an existing program as
15
described in paragraph (1).
16
(b) USE OF FUNDS.—Grant funding may be used for
17
the development, maintenance, or staffing of digital con-
18
tact tracing programs, associated outreach and marketing,
19
or other activities identified by a State, Tribal, or terri-
20
torial public health agency that advance the effectiveness
21
and reach of digital contact-tracing technologies.
22
(c) FUNDING DISQUALIFICATION.—If a State, Trib-
23
al, or territorial public health agency develops or procures
24
any digital contact-tracing technology with respect to
25
COVID–19 that does not meet each of the requirements
26
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
3
•S 5027 IS
listed in subsection (d), such State, Tribal, or territorial
1
public health agency shall be ineligible to receive or con-
2
tinue to receive—
3
(1) any funds through a grant under this sec-
4
tion; and
5
(2) any other Federal funds, including under
6
the CARES Act (Public Law 116–136), for any dig-
7
ital contact-tracing technology with respect to
8
COVID–19.
9
(d) DIGITAL CONTACT-TRACING REQUIREMENTS.—
10
A State, Tribal, or territorial public health agency may
11
use a grant under this section for digital contact-tracing
12
technology, as described in subsections (a) and (b), only
13
if the technology meets each of the following requirements:
14
(1) The technology shall be voluntary for the
15
user and provide to the user complete and clear in-
16
formation on the intended use and processing of
17
data collected by the technology. To be voluntary for
18
the user, the technology shall meet requirements in-
19
cluding each of the following:
20
(A) Use of the technology and of contact-
21
tracing data collected using the technology shall
22
be predicated on the user’s affirmative consent.
23
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
4
•S 5027 IS
(B) Use of the technology shall not be a
1
condition for the reception of government bene-
2
fits.
3
(C) Use of the technology shall not be
4
made a condition of employment or employment
5
status.
6
(2) The technology shall limit the collection of
7
data by the technology to only the data that is nec-
8
essary to meet contact tracing objectives, includ-
9
ing—
10
(A) the status of any person as an infected
11
or potentially infected person; and
12
(B) the proximity of a person to someone
13
who is symptomatic or has tested positive.
14
(3) The technology—
15
(A) shall delete or de-identify any contact-
16
tracing data that is individually identifiable in-
17
formation not later than the date that is 30
18
days after the end of the COVID–19 emergency
19
declaration; and
20
(B) shall include notifications to prompt
21
users to disable or completely remove any dig-
22
ital contact-tracing technology where practical.
23
(4) The technology shall have robust contact
24
detection specifications, including for distance and
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
5
•S 5027 IS
time, that allow for detection consistent with guid-
1
ance of the Centers for Disease Control and Preven-
2
tion on COVID–19.
3
(5) The technology shall ensure that the storing
4
of proximity and any contact-tracing data is
5
encrypted to the maximum extent possible.
6
(e) PLAN FOR INTEROPERABILITY.—As a condition
7
on receipt of a grant under this section, a State, Tribal,
8
or territorial public health agency shall—
9
(1) develop and make publicly available a plan
10
for how the digital contact-tracing technology of the
11
agency with respect to COVID–19 augments—
12
(A) traditional contact tracing efforts, if
13
applicable; and
14
(B) statewide efforts to prevent, prepare
15
for, and respond to COVID–19; and
16
(2) include in such plan a description of the
17
agency’s efforts to ensure that the digital contact-
18
tracing technologies of the agency with respect to
19
COVID–19 are interoperable with the digital con-
20
tact-tracing technology and public health agency
21
databases of other jurisdictions with respect to
22
COVID–19; and
23
(3) ensure that data collected by the digital
24
contact-tracing technology of the agency—
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
6
•S 5027 IS
(A) is accessed and processed only by pub-
1
lic health authorities (or their designees); and
2
(B) is not shared with any person, or
3
accessed or used by any person, for any purpose
4
other than diagnosis, containment, treatment,
5
or reduction of, or research into, COVID–19.
6
(f) INDEPENDENT SECURITY ASSESSMENTS.—
7
(1) IN GENERAL.—As a condition on receipt of
8
a grant under this section, a State, Tribal, or terri-
9
torial public health agency shall—
10
(A) establish procedures for completing or
11
obtaining independent security assessments of
12
digital contact tracing infrastructure to ensure
13
that physical and network security is resilient
14
and secure; and
15
(B) develop a process to address the miti-
16
gation
or
remediation
of
the
security
17
vulnerabilities discovered during such inde-
18
pendent security assessments.
19
(2) SOURCE CODE.—A State, Tribal, or terri-
20
torial public health agency should consider making
21
public the source code of the digital contact-tracing
22
technology used by the agency.
23
(g) APPLICATION.—To seek a grant under this sec-
24
tion, an eligible State, Tribal, or territorial public health
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
7
•S 5027 IS
agency shall submit an application in such form, in such
1
manner, and containing such information and assurances
2
as the Director may require.
3
(h) SECURING DIGITAL CONTACT-TRACING DATA.—
4
(1) IN
GENERAL.—The provisions of the
5
HIPAA privacy and security law (as defined in sec-
6
tion 3009(a)(2) of the Public Health Service Act (42
7
U.S.C. 300jj–19(a)(2))) shall apply to a State, Trib-
8
al, or territorial public health agency receiving a
9
grant under subsection (a) with respect to individ-
10
ually identifiable health information (as defined in
11
section 1171(a)(6) of the Social Security Act (42
12
U.S.C. 1320d(a)(6))) received by, maintained on, or
13
transmitted through a contact tracing program de-
14
scribed in such subsection (a) in the same manner
15
as such provisions apply with respect to such infor-
16
mation and a covered entity (as defined in section
17
13400(3)
of
the
HITECH
Act
(42
U.S.C.
18
17921(3))).
19
(2) BUSINESS ASSOCIATES.—
20
(A) IN GENERAL.—Any entity with a con-
21
tract in effect with an agency described in para-
22
graph (1) for the development, maintenance, or
23
operation of a program described in such para-
24
graph shall be deemed to be a business asso-
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
8
•S 5027 IS
ciate of such agency for purposes of subtitle D
1
of the HITECH Act (42 U.S.C. 17921 et seq.).
2
(B) REVISION OF SAMPLE AGREEMENT.—
3
Not later than 180 days after the date of the
4
enactment of this Act, the Secretary shall revise
5
the sample business associate agreement provi-
6
sions published on January 25, 2013, to take
7
account of the provisions of this subsection.
8
(C) EFFECTIVE DATE.—The provisions of
9
subparagraph (A) shall apply beginning on the
10
day after the Secretary revises the provisions
11
described in subparagraph (B).
12
(i) LIMITATION ON USE OF DATA.—Data generated
13
in connection with the operation of digital contact-tracing
14
technology funded pursuant to this section may not be
15
used for any punitive purpose, including law enforcement,
16
immigration enforcement, or criminal prosecution. Such
17
data and any information derived from it, whether in
18
whole or in part, may not be received as evidence in any
19
trial, hearing, or other proceeding in or before any court,
20
grand jury, department, officer, agency, regulatory body,
21
legislative committee, or other authority of the United
22
States, a State, or a political subdivision thereof.
23
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
9
•S 5027 IS
(j) REPORT
TO CONGRESS.—Not later than 24
1
months after the date of enactment of this Act, the Comp-
2
troller General of the United States shall—
3
(1) evaluate the outcome of the grants awarded
4
under this section, including an assessment of the
5
impact of the implementation of digital contact trac-
6
ing programs funded through such grants on the
7
spread of COVID–19; and
8
(2) submit to the Congress a report on the re-
9
sults of such evaluation.
10
(k) DEFINITIONS.—In this section:
11
(1) AFFIRMATIVE
EXPRESS
CONSENT.—The
12
term ‘‘affirmative express consent’’ means an affirm-
13
ative act by an individual that clearly and conspicu-
14
ously communicates the individual’s authorization
15
for an act or practice, in response to a specific re-
16
quest that—
17
(A) is provided to the individual in a clear
18
and conspicuous disclosure that is separate
19
from other options or acceptance of general
20
terms;
21
(B) includes a description of each act or
22
practice for which the individual’s consent is
23
sought and—
24
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
10
•S 5027 IS
(i) is written clearly and unmistakably
1
stated; and
2
(ii) includes a prominent heading that
3
would enable a reasonable individual to
4
identify and understand the act or prac-
5
tice; and
6
(C) cannot be inferred from inaction.
7
(2) CONTACT-TRACING DATA.—The term ‘‘con-
8
tact-tracing data’’ means information linked or rea-
9
sonably linkable to a user or device, that—
10
(A) concerns the COVID–19 pandemic;
11
and
12
(B) is gathered, processed, or transferred
13
by digital contact-tracing technology.
14
(3) COVID–19 EMERGENCY
DECLARATION.—
15
The term ‘‘COVID–19 emergency declaration’’ has
16
the meaning given to such term in section
17
1135(g)(1)(B) of the Social Security Act (42 U.S.C.
18
1320b–5).
19
(4) DE-IDENTIFY.—The term ‘‘de-identify’’
20
means to ensure that information cannot reasonably
21
identify, relate to, describe, be capable of being asso-
22
ciated with, or be linked, directly or indirectly, to a
23
particular individual.
24
(5) DESIGNEE.—The term ‘‘designee’’—
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
11
•S 5027 IS
(A) subject to subparagraph (B), means
1
any person or entity, other than a public health
2
agency, that collects, processes, or transfers
3
contact-tracing data in the course of performing
4
a service or function on behalf of, for the ben-
5
efit of, under instruction of, and under contrac-
6
tual agreement with a public health authority;
7
and
8
(B) excludes any Federal, State, Tribal,
9
territorial, or local law (including immigration
10
law) enforcement personnel or entity.
11
(6)
DIGITAL
CONTACT-TRACING
TECH-
12
NOLOGY.—
13
(A) IN GENERAL.—The term ‘‘digital con-
14
tact-tracing technology’’ means a website, on-
15
line application, mobile application, mobile oper-
16
ating system feature, or smart device applica-
17
tion that is designed, in part or in full, for the
18
purpose of—
19
(i) determining that a contact incident
20
has occurred relating to the COVID–19
21
pandemic; and
22
(ii) taking consequent steps such as
23
reporting the incident to a public health
24
authority or user, or providing guidance or
25
VerDate Sep 11 2014
19:58 Jan 01, 2021
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\S5027.IS
S5027
12
•S 5027 IS
instructions to the user of the mobile de-
1
vice or the user’s household.
2
(B) LIMITATIONS.—Such term does not in-
3
clude any technology to assist individuals to
4
evaluate whether they are experiencing COVID–
5
19 symptoms to the extent the technology is not
6
used as described in subparagraph (A).
7
(7) DIRECTOR.—The term ‘‘Director’’ means
8
the Director of the Centers for Disease Control and
9
Prevention.
10
(8) MOBILE APPLICATION.—The term ‘‘mobile
11
application’’ means a software program that runs on
12
the operating system of a mobile device.
13
(9) MOBILE
DEVICE.—The term ‘‘mobile de-
14
vice’’ means a smartphone, tablet computer, or simi-
15
lar portable computing device that transmits data
16
over a wireless connection.
17
(10) SOURCE CODE.—The term ‘‘source code’’
18
is the programming instruction for a computer pro-
19
gram in its original form and saved in a file.
20
(11) TRADITIONAL
CONTACT
TRACING.—The
21
term ‘‘traditional contact tracing’’ means contact
22
tracing by traditional means prior to contemporary
23
digital contact tracing.
24
VerD
[Text truncated for display. Full text available on Congress.gov.]
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.